Medical Robotics Market to Reach $31.3 Billion by 2035, Growing at 10.8% CAGR | Intuitive Surgical, Stryker, Medtronic Among Key Players

The global medical robotics market, valued at USD 10.1 billion in 2024, will reach USD 11.2 billion in 2025 and is projected to hit USD 31.3 billion by 2035, growing at a CAGR of 10.8% over the forecast period. This near-tripling of market value over a decade reflects how deeply robotic systems are embedding themselves across surgical suites, rehabilitation centers, and elderly care facilities worldwide.

To explore the complete findings, request a free sample of the report at:
https://www.rootsanalysis.com/reports/medical-robotics-market/request-sample.html

Medical Robotics Market Overview
Medical robots are no longer specialty tools confined to a handful of teaching hospitals. They now perform a broad range of clinical functions: executing minimally invasive surgeries with sub-millimeter precision, restoring mobility in stroke and spinal cord injury patients through wearable exoskeletons, and providing companionship and cognitive support to an aging global population. The shift away from open surgeries toward minimally invasive procedures has accelerated demand for surgical robots, which currently hold a 50% share of the overall medical robotics market.

The macro forces driving this market are concrete and measurable. The United Nations projects that the global population aged over 65 years will rise from 761 million in 2021 to 1.6 billion by 2050, creating sustained demand for rehabilitation and care robots that reduce strain on healthcare workers while improving patient outcomes. Simultaneously, healthcare systems worldwide face chronic workforce shortages, making automation a structural necessity rather than a discretionary investment.

Recent industry activity confirms that investment is accelerating, not decelerating. In October 2025, CMR Surgical announced early adoption of NVIDIA's IGX Thor platform, integrating it with its Versius surgical robotic system. In June 2025, China launched an initiative directing companies to trial over 200 robotic systems across 200+ households for elderly care, or to deploy at least 20 systems in 20 institutions. These are not pilot curiosities; they signal serious national-level commitment to robotic healthcare infrastructure.

Key Growth Drivers
Minimally Invasive Surgery Adoption: Patients and surgeons are both choosing robotic-assisted procedures for their documented benefits: fewer incisions, reduced scarring, lower infection risk, and faster recovery times. This shift has made surgical robots a standard capital purchase for hospitals competing on clinical outcomes. The orthopedic surgery segment, in particular, is growing faster than most surgical categories as companies move toward open-system models that free customers from single-vendor implant purchasing.

Artificial Intelligence Integration: Robotics companies are embedding AI and machine learning directly into their systems to improve anomaly detection in medical imaging, reduce the likelihood of human errors during surgery, and strengthen surgeon decision-making in real time. AI-assisted robots are also enabling telesurgery, where surgeons operate remotely through tele-operated systems, overcoming geographic barriers for patients in underserved regions. In September 2023, Shanghai MicroPort MedBot partnered with West China Hospital and Tibet People's Hospital to conduct 5G remote surgery experiments on high-altitude terrain.

Aging Population and Workforce Pressures: Rising numbers of elderly patients with chronic illness and mobility impairment are creating demand that human caregivers alone cannot fill. Care robots and social robots now monitor health, deliver medication reminders, and provide cognitive stimulation, reducing burnout among healthcare professionals while improving the consistency of patient care.

Rehabilitation Technology Breakthroughs: Nearly 65% of deals in the rehabilitation robots market were signed in the three years since 2021, indicating rapid commercialization. Wearable exoskeletons are helping partially and fully paralyzed patients restore upper and lower extremity movement, with distribution agreements accounting for 28% of all partnership activity in this segment since 2017. In July 2023, Wandercraft supplied its Atalante X exoskeletons to Lucy Montoro, a Brazilian neurological rehabilitation center, for patient rehabilitation and medical research.

Cloud and Remote Surgery Expansion: While on-premise deployments currently hold nearly 90% of the market, cloud and remote surgery models are growing at a faster CAGR. As connectivity infrastructure improves and regulatory frameworks catch up, remote surgical systems will extend specialist-level care to hospitals that currently lack qualified surgeons.

Medical Robotics Market Segmentation
The medical robotics market divides into two primary robot types: surgical robots and rehabilitation robots. Surgical robots command the larger share at 50% of the total market, while rehabilitation robots are growing at a comparatively higher CAGR through 2035. Within the surgical segment, services generate the highest revenue among all developer offerings, a trend driven by the increasing complexity of AI-integrated systems that require extensive surgeon training and ongoing maintenance. The orthopedic surgery segment captures the highest share by procedure type and is forecast to grow faster than general, abdominal, urologic, and other surgical categories.

Rehabilitation robots segment by body part covered (lower body, upper body, and full body), with lower body exoskeletons currently dominating. Powered exoskeletons outsell hybrid models, primarily because their higher average prices translate to greater revenue despite lower unit volume. For end users, hospitals lead the market, supported by their higher surgical throughput, institutional purchasing power, and the need for precision equipment that justifies the capital cost of robotics systems. The therapies and treatment application area holds the majority share, though the diagnostics sub-segment is growing at a faster CAGR.

For a detailed segmentation breakdown and forecast data, download a free sample report at:
https://www.rootsanalysis.com/reports/medical-robotics-market/request-quote.html

Regional Insights
North America holds approximately 70% of the global medical robotics market and will maintain that leadership position through 2035. The region benefits from a dense network of advanced hospitals, a mature regulatory environment for robotic devices, strong venture and institutional investment in healthcare technology, and the headquarters presence of several of the industry's largest players, including Intuitive Surgical and Stryker. High per-procedure reimbursement rates in the United States make it financially viable for hospitals to absorb the capital cost of surgical robot installations.

Asia-Pacific is the fastest-growing region by CAGR over the forecast period. China's government-backed initiatives in robotic eldercare, combined with rising healthcare spending in India, Japan, South Korea, and Southeast Asia, are creating new market entry opportunities. The 5G-enabled remote surgery experiments underway in China suggest that Asia-Pacific may eventually lead innovation in telesurgery applications. Europe holds a meaningful share driven by Germany, France, and the United Kingdom, where both public health systems and private hospitals are investing in robotic-assisted procedures to manage growing surgical backlogs.

Competitive Landscape
The medical robotics market includes more than 110 surgical robot developers and approximately 80 rehabilitation robot developers, according to the Roots Analysis report. Key players include Intuitive Surgical, Johnson & Johnson, Medtronic, Stryker, Zimmer Biomet, Smith+Nephew, Siemens Healthineers, CYBERDYNE, Ekso Bionics, Hocoma, Fourier Intelligence, Panasonic, Renishaw, Gloreha, Hexar Humancare, Guangzhou Yikang, and ExoAtlet.

The dominant competitive dynamic is consolidation through acquisition. Since 2019, acquisitions have accounted for 14% of all deals in the surgical robotics space, as established players buy their way into new technology capabilities and geographic markets. Startups are challenging incumbents primarily through AI software integration, open-architecture implant compatibility, and compact robot designs suited to smaller surgical facilities. The battleground over the next decade will likely be interoperability and data ownership, as AI-driven surgical systems generate proprietary clinical datasets that become a durable competitive advantage.

Browse Full Report Description + Research Methodology + Table of Content + Infographics here:
https://www.rootsanalysis.com/reports/medical-robotics-market.html

Contact Details for Roots Analysis
Chief Executive: Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com
Website: https://www.rootsanalysis.com/

About Roots Analysis
Roots Analysis is a global leader in the market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

This release was published on openPR.